Another thing is why is Generex having to submit another pre-IND? They submitted one already, so they knew what they had to do. They received instructions, they knew what they needed to do, all they supposedly had to do was put in the IND.

Why do they have to go the same route as before with a pre-IND once again to get approval to submit another IND? It's the entire process all over again, when they just did this same route.

Did they not learn from the first time or did they make some mistake and the FDA told them they had to start over from scratch which then is not a good sign once again.